Normal human diploid cells senesce in vitro and in vivo after a limited number of cell divisions. This process known as cellular senescence is an underlying cause of aging and a critical barrier for development of human cancers. We demonstrate here that reexpression of functional pRB alone in RB/p53-defective tumor cells via a modi®ed tetracycline-regulated gene expression system resulted in a stable growth arrest at the G0/G1 phase of the cell cycle, preventing tumor cells from entering S phase in response to a variety of mitogenic stimuli. These cells displayed multiple morphological changes consistent with cellular senescence and expressed a senescence-associated b-galactosidase biomarker. Further studies indicated that telomerase activity, which was assumably essential for an extended proliferative life-span of neoplastic cells, was abrogated or repressed in the tumor cell lines after induction of pRB (but not p53) expression. Strikingly, when returned to an nonpermissive medium for pRB expression, the pRB-induced senescent tumor cells resumed DNA synthesis, attempted to divide but most died in the process, a phenomenon similar to postsenescent crisis of SV40 T-antigentransformed human diploid ®broblasts in late passage. These observations provide direct evidence that overexpression of pRB alone in RB/p53-defective tumor cells is sucient to reverse their immortality and cause a phenotype that is, by all generally accepted criteria, indistinguishable from replicative senescence. The results suggest that pRB may play a causal role in the intrinsic cellular senescence program.
Introduction
Normal somatic cells do not divide inde®nitely. The ®nite replicative lifespan of cells leads to an eventual arrest of cell division by a process termed replicative senescence (Goldstein, 1990; Campisi, 1996) . Replicative senescence entails an irreversible arrest of cell proliferation and altered cell function (Campisi, 1996) . In addition, senescent cells acquire resistance to apoptotic cell death (Wang, 1995) . Cell senescence is believed to be an underlying cause of aging. During the evolution of aging, senescence may have been selected, at least in mammals, to help ensure the relative freedom from cancer in earlier life. Escape of cells from senescence leads to immortalization and oncogenesis (Goldstein, 1990) . Therefore, studies on the mechanism of cellular senescence may provide insights into both the cancer and aging processes.
The retinoblastoma tumor suppressor gene (RB) encodes a nuclear phosphoprotein of *110 kDa (pRB), which is dierentially phosphorylated during the cell cycle. The timing of pRB phosphorylation led to an attractive functional model (Weinberg, 1995) . This model suggests that pRB be a guardian of the R point, a distinct time point at several hours before the onset of S phase (Pardee, 1989) . pRB allows the cell cycle clock to control the expression of numerous genes that mediate advance of the cell through the R point gate. Loss of normal pRB function for various reasons derpives the cell of an important mechanism for braking cell proliferation. On the other hand, it has been reported that senescent cells failed to phosphorylate (inactivate) pRB and did not enter S phase (Stein et al., 1990; Futreal and Barrett, 1991) . Neither of the studies, however, was able to distinguish whether the lack of pRB phosphorylation in senescent cells was the cause or consequence of growth arrest (Futreal and Barrett, 1991) .
Studies done in our laboratory and by many others have indicated that replacement of the normal RB gene into RB-defective tumor cells could suppress their tumorigenic activity in nude mice (Huang et al., 1988; Takahashi et al., 1991; Goodrich and Lee, 1993; Zhou et al., 1994; Xu, 1997) . pRB may also play a role in elicitation of immunogenicity of tumor cells (Lu et al., 1994 , inhibition of angiogenesis (Dawson et al., 1995) and tumor invasiveness (Li et al., 1996) . However, it was found that long-term stable clones of the RB-reconstituted tumor cells can be isolated in culture that grew just as rapidly as their parental lines. Thus, there has been a tendency in the literature to separate the inhibition of cell growth by RB replacement in RB-defective tumor cells from its tumor suppression function (Chen et al., 1992; Zhou et al., 1994; Xu, 1997) . We suspect that the dissociation of tumorigenicity from growth rates of the tumor cells following RB-replacement might be attributed to the selection bias during the cloning process. Therefore, in the present studies, a modi®ed tetracycline (Tc)-regulatable gene expression system was used for establishing RB-reconstituted tumor cell clones. Because expression of pRB in the tumor cells can be turned o during the cloning process, the possible bias towards selecting rapid growing, pRB-resistent tumor cell clones after RB-reconstitution was minimized by using this system.
By characterizing these long-term stable tumor cell clones with Tc-regulatable gene expression, our studies provided direct evidence for pRB-mediated tumor cell senescence and a new link between the RB tumor suppressor gene and telomerase, whose activity is thought to be responsible for stabilizing telomere length in most immortal and cancer cells (Counter et al., 1992; de Lange, 1994; Kim et al., 1994; .
Results

pRB-mediated irreversible growth cessation of tumor cells
We have recently modi®ed the original tetracycline (Tc)-regulatable gene expression system (Gossen and Bujard, 1992) . The modi®cation warrants lower constitutive expression of the tTA transactivator, therefore eliminates the squelching eects of its VP-16 activating domains on host cell growth. By using this system, we established dozens of long-term stable tumor cell clones, in which expression of the wildtype pRB can be reversibly turned on and o without signi®cant leakage (see Materials and methods). The RB-reconstituted tumor cell clones were obtained, respectively, from the breast carcinoma cell line, MDA-MB-468, the osteosarcoma cell line Saos-2 and the bladder carcinoma cell line 5637. These tumor cell lines were chosen as host cells since they were known to contain both RB and p53 mutations (Wang et al., 1993; Chen et al., 1990; Berry et al., 1996; Masuda et al., 1987) . As measured by Western blotting, pRB protein induced in the tumor cells reached the highest level about 24 h after removal of tetracycline from the cell culture medium, and then became completely dephosphorylated within 24 ± 40 h (data not shown). The eects of induction of pRB expression on tumor cell growth were subsequently examined in representative clones by measuring growth curves and ( 3 H) thymidine incorporation , and by¯ow cytometric analysis (Nicoletti et al., 1991) . Cell growth and DNA synthesis of all the long-term tumor cell clones studied ceased 24 ± 48 h after pRB expression was induced ( Figure 1A and data not shown). The great majority of the tumor cells were arrested at G0/G1 phase of the cell cycle ( Figure 1B) . After a 4-day induction of pRB expression in Tc-free medium, the growth cessation of the tumor cells was irreversible by stimulation with a variety of mitogens, such as serum growth factors, phytohemagglutinin (PHA) and concanavalin A (Con A). This was determined by continuous¯at growth curves as shown in Figure 1A and failure of the tumor cells to incorporate [ Furthermore, as measured by DNA fragmentation assay, a small amount of lower molecular weight DNAs were often observed in DNA samples prepared from RB-reconstituted Saos-2 tumor cells grown in non-permissive but not permissive conditions for pRB expression. This ®nding suggested a low level of spontaneous apoptosis of the RB-defective tumor cell culture, which was inhibited by induction of pRB expression. In addition, switching on pRB expression in the RB-reconstituted 5637 and MDA-MB-468 tumor cell lines also inhibited IFN-g induced apoptotic cell death (data not shown). A more detailed characterization of these cell lines regarding the role of pRB in regulating apoptotis will be described elsewhere.
Expression of senescence-associated b-galactosidase
Dimri et al. recently reported a biomarker that identi®es senescent human cells in culture and in aging skin in vivo. This marker, termed senescenceassociated b-galactosidase (SA-b-gal), is expressed by senescent, but not pre-senescent ®broblasts. SA-b-gal was also absent from immortal cells but was induced by genetic manipulations that reversed immortality (Dimri et al., 1995) . As shown in Figure 3 , young (early passage) human WI-38 ®broblasts were SA-b-gal negative, whereas the senescent (at population doubling level greater than 52) WI-38 cells were strongly SA-bgal positive, which provided a valid control for the SAb-gal assay. The Tc-responsive RB-reconstituted tumor cell clones were totally SA-b-gal negative in the presence of Tc (i.e., in RB 7 status), and the majority of the tumor cells became SA-b-gal positive after induction of pRB expression for 4 ± 5 days in Tc-free medium ( Figure 3d , f and h). The detection of this senescence-associated biomarker in the tumor cells was coincident with the irreversible growth cessation of the tumor cell populations ( Figure 1A ). The intensity of the SA-b-gal staining of the induced RB + tumor cells, however, was variable depending on the tumor cell types.
Re-expression of pRB (but not p53) in tumor cells inhibited telomerase activity
Since telomerase has recently emerged as an attractive candidate for a regulator in cellular senescence Klingelhutz et al., 1996) , we compared the eects of pRB and p53 replacement on the telomerase activity of the host tumor cells. In this connection, we have also established several long-term stable tumor cell clones with Tc-regulatable wild-type p53 expression from the osteosarcoma cell line, Saos-2 (manuscript in preparation). A telomeric repeat ampli®cation protocol (TRAP) assay as recently described (Kim et al., 1994) was used in the present study to measure telomerase activity in tumor cells before and after induction of pRB (or p53) expression. A representative autoradiographic image is shown in Figure 4 . Prior to induction of pRB expression, the RB-reconstituted tumor cell clones from all three RB/ p53-defective tumor types examined were positive for telomerase activity, whereas the relative telomerase activity was *15 to 4100 times lower in the tumor cells after turning on the pRB expression as estimated by densitometry of the digitized image. In fact, the telomerase activity was nearly non-detectable in the pRB-expressing MDA-MB-468 and Saos-2 tumor cells as illustrated in Figure 4 , lanes 6 and 10. In contrast, although induction of wild-type p53 expression in Saos-2 did result in growth arrest of the RB 7 /p53 null tumor cells (data not shown), the p53-reconstituted Saos-2 tumor clones persistently exhibited positive telomerase activity, which was not aected by their p53 status. So these dierences in telomerase activity cannot be explained simply as a dierence in cell proliferation.
Postsenescent crisis of pRB-induced senescent tumor cells after withdrawal of pRB
The pRB-induced tumor cell senescence was stringently dependent on the continued expression of the functional pRB. As shown above, after induction of Figure 1 The eects of Tc-regulated pRB expression on tumor cell growth (A) Representative long-term clones, one each from the RB-reconstituted osteosarcoma (Saos-2, clone 11), breast carcinoma (MDA-MB-468, clone 19-4), and bladder carcinoma (5637, clone 34-6) cell lines, were grown in the presence of 0.5 mg/ml of Tc (&) versus absence of Tc (*). Cell growth of the tumor cells stopped 1 ± 2 days after pRB expression was turned on in Tc-free medium. The growth cessation was irreversible at day 4 after stimulation (arrows) with fresh medium containing 15% serum (Saos-2), 10% serum plus 2 mg/ml phytohemagglutinin (PHA) (MDA-468) or 10% serum plus 4 mg/ml of concanavalin A (Con A) (5637) for 72 h. (B) DNA content¯ow cytometric pro®les are illustrated for a representative stable RB-reconstituted Saos-2 osteosarcoma cell line (clone 11). For¯ow cytometric analysis (Nicoletti et al., 1991) , an asynchronous population of tumor cells was grown in complete tissue culture medium in the presence of 0.5 mg/ml Tc for 48 h (the tumor cells were all RB 7 ) (a); or in the absence of Tc for 48 h (b) and 96 h (c). respectively (in Tc-free medium, the pRB expression was turned on). The perentages of the total gated cells falling into each phase of the cell cycle are indicated. The great majority of tumor cells were arrested in G0/G1 phase after re-expressing pRB (b, c). It should be realized that the¯ow cytometry for quantitative cell cycle analysis is imperfect, and a small number of residual cells falling into the M2 and M3 areas may re¯ect partly aneuploidy or hyperploidy of the tumor cell population pRB expression in Tc-free medium for 4 or more days, the RB-reconstituted MDA-MB-468, Saos-2, and 5637 tumor cells became senescent. When these tumor cells returned to an non-permissive medium for pRB expression, however, a large number of tumor cells were observed that lost cell-cell adherence, detached from the Petri dishes and died. To further characterize this phenomenon, a combined method was employed involving pRB immunocytochemical staining and [ 3 H]thymidine in situ labeling of the tumor cells. It was found that after adding 0.5 mg/ml of Tc back to the RB-reconstituted Saos-2 tumor cell cultures that had been maintained in Tc-free medium for 4 ± 5 days, nearly all tumor cells were depleted of the exogenous pRB and became RB 7 at day 6 (data not shown). Subsequently, at day 9 ± 10, the tumor cells resumed DNA synthesis, the majority of which however had strikingly aberrant nuclei. They attempted to divide but most died in the process ( Figure 5 ). These tumor cells displayed a phenotype, showing remarkable similarity to postsenescent crisis of the T-antigen-transformed human cells in late passage (Stein, 1985) . 
Discussion
In summary, we have demonstrated that re-expression of functional pRB in RB-defective tumor cells induced growth cessation concurrently with inhibition of telomerase activity. The tumor cells irreversibly lost mitogen responsiveness, entering a viable G1-arrested state. They also exhibited pRB-dependent SA-b-gal positivity (a senescence-associated biomarker) and resistance to apoptotic cell death. Of note, replacement of either wild-type pRB or p53 in the RB 7 /p53 null Saos-2 was able to block tumor cell growth at the population level, but only pRB induced inhibition of telomerase. Furthermore, withdrawal of pRB in pRBinduced senescent tumor cells led to a crisis-like phenotype. These observations, taken together, sug- , d) , 5637, clone 36-9 (e, f) and Saos-2, clone 11 (g, h) with Tcregulatable pRB expression were cultured either in the presence of 0.5 mg/ml of Tc (no pRB expression) (c, e & g), or in Tc-free medium (the permissive condition for pRB expression) (d, f & h) for 4 days, and were processed for SA-b-gal assay (Dimri et al., 1995) . The human young (a, SA-b-gal-negative) and senescent (b, SA-b-gal-positive) WI-38 ®broblasts served as internal controls for the assay gest pRB might be causally involved in the cellular senescence program. To our knowledge, these results showed the ®rst direct evidence that overexpression of pRB alone in a variety of RB-defective tumor cells was sucient to reverse their immortality and cause bona ®de replicative senescence. Since all three RB-defective tumor cell lines we examined also have p53 mutations, the pRB-mediated tumor cell senescence apparently do not require wild-type p53 function.
Recent studies suggest the existence of a critical or threshold telomere length in senescent cells (Allsopp and Harley, 1995) . The loss of telomeric DNA from the ends of chromosomes with each cell division eventually reaches a critical point that may result in genetic instability and trigger replicative senescence of normal somatic cells. Eukaryotic telomeres are maintained by telomerase, a ribonucleoprotein enzyme that extends chromosomal ends with telomeric TTAGGG repeat elements. Telomerase is stringently repressed in normal human somatic tissues with a few exceptions (Counter et al., 1995; Harle-Bachor and Boukamp, 1996) , but is reactivated in most human tumor cells. Immortal and cancer cells apparently use telomerase to stabilize their telomere length (Counter et al., 1992; de Lange, 1994; Kim et al., 1994) .
In this report we provide a new link between pRB and telomerase. It is demonstrated by a telomeric repeat ampli®cation protocol (TRAP) assay that reexpression of pRB in RB-defective tumor cells inhibits telomerase activity. Because of the high sensitivity of the polymerase chain reaction (PCR)-based TRAP assay, which detects the enzyme activity in a very small number of telomerase positive cells and the diculty in obtaining absolutely pure RB-reconstituted cell clones, we believe that the eectiveness of pRB re-expression on inhibition of telomerase activity in RB-defective tumor cells was even greater than it had been detected by the in vitro assay. It is also noteworthy that, when maintained in non-permissive conditions for pRB (or p53) expression, the pRBreconstituted Saos-2 clone apparently had much lower telomerase activity than the p53-reconstituted Saos-2 clone (Figure 4, lanes 3 and 5) . The dierence implies that, even before switching-on of the pRB expression in Tc-free medium, there must be low baseline expression of pRB from the Tc-responsive promoter in Saos-2 cells (Gossen and Bujard, 1995) . The leakiness of pRB in pRB-reconstituted tumor cells under non-permissive conditions is below the immunodetection threshold for pRB protein , but it might be sucient to inhibit the most telomerase activity. Since the tumor cells lacking telomerase activity likely resume telomere decline, this would eventually trigger the intrinsic cellular senescence program if it remains intact in the tumor cells. counterparts (lanes 5, 7 and 9). In contrast, p53 re-expression apparently had no eect on telomerase activity of the RB 7 / p53 null Saos-2 tumor cells (lanes 3 and 4). Lane 1, control with known telomerase-positive cell extract; lane 2, normal human ®broblast IMR-90 cell extract (telomerase-negative). An internal positive control (a 36 bp template) for the PCR ampli®cation was included in each reaction mixture. The autoradiographic image shown here is from a single experiment representative of at least six independent experiments with similar results Figure 5 Withdrawal of pRB expression in pRB-mediated senescent Saos-2 tumor cells led to a postsenescent crisis-like phenotype. Approximately 3 days after turning o pRB expression, DNA synthesis resumed in the postsenescent tumor cells accompanied by strikingly aberrant nuclei in two independent RB-reconstituted Saos-2 clones, clone 11 (c) and clone 15 (d). By comparison, S phase tumor cells from the parental RB 7 Saos-2 (a) and the RB-reconstituted Saos-2 clone 11 (b) continuously grown in Tc-containing medium for 9 days had apparentlỳ normal' nuclei.
3 H thymidine in situ labeling of the tumor cells was done as previously described 
Materials and methods
Establishing tumor cell lines with Tc-regulatable pRB expression
The original multiple-plasmid tetracycline repressor/operator-based regulatory system was generously provided by Dr H Bujard (Gossen and Bujard, 1992) . This system has been further improved in our laboratory by utilizing a modi®ed tTA expression cassette, that warrants lower constitutive expression of the tTA transactivator. The modi®cation eliminates the squelching eect of its activating domain (a portion of the herpes simplex virus VP-16 protein) on host cell growth (Gill and Ptashne, 1988) . Our modi®ed system is also more suitable for establishing long-term stable cell lines with regulatable gene expression since it is now contained within a single plasmid (manuscript in preparation). All RB-reconstituted tumor cell lines used in the present studies were subjected to at least two rounds of subcloning following the initial plasmid transfection and are considered pure clones. The homogeneity of these clones was veri®ed by pRB nuclear staining. In addition, a panel assay was used to ensure stable expression of the functional pRB under permissive conditions. The RB-reconstituted tumor cells were all RB 7 in the presence of 0.5 mg/ml of Tc in culture medium; while the great majority (499%) of the cells became RB + at 24 h after removal of Tc as shown by immunocytochemical staining (please note that tetracycline is an`inhibitor' rather than an`inducer' in this tetracycline-responsive expression system).
Flow cytometric analysis
Single cell suspensions collected at each time point were ®xed with paraformaldehyde and ethanol before propidium iodide (PI) (Sigma) staining. All pro®les were generated using a FACScan¯ow cytometer (Becton-Dickinson). The ®rst peak (M1) contains cells with diploid DNA in G0/G1, the second peak (M3) with twice the PI-¯uorescence intensity contains tetraploid G2/M cells, and the area between the two peaks (M2) represents the total number of cells in S phase (Nicoletti et al., 1991) .
SA-b-gal assay
The assay was done as previously described (Dimri et al., 1995) . Brie¯y, the cells were ®xed in 2% formaldehyde/ 0.2% glutaraldehyde for 5 min and stained with 5-bromo-4-chloro-3-indolyl b-D-galactoside (X-Gal) at pH 6.0 for 6 h. The staining solution contained 1 mg/ml of X-Gal, 40 mM of citric acid/sodium phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl and 2 mM MgCl 2 .
Telomeric repeat ampli®cation protocol (TRAP) assay
The methodology, according to the technical manual, was modi®ed from the original TRAP assay as described by Kim et al. (1994) . In short, *10 6 cells grown in a 100-mm Petri dish were harvested and resuspended in 200 ml of icecold lysis buer for 30 min on ice, followed by centrifugation at 100 000 g for 30 min at 48C. The supernatant was diluted to 0.5 mg protein/ml, of which 2 ml was used for each TRAP assay. The telomerase reaction was carried out at 308C for 30 min, which was followed by a 2-step PCR ampli®cation with g-32 P-labeled TS primer (948C, 30 s and 608C, 30 s for 33 cycles). The PCR-ampli®ed telomerase extension products were subjected to electrophoresis on a 12.5% polyacrylamide gel.
